Sporadic Medullary Thyroid Carcinoma with Paraneoplastic Cushing Syndrome

Figure 1

Calcitonin levels while on Vandetanib therapy. The graph depicts levels at baseline before the treatment was started, followed by initiation of Vandetanib, and subsequent rise in calcitonin levels after the therapy was stopped.